Biopharma EHS Podcast Episode No. 16
Update: 2011-05-14
Description
In this podcast, Dean M. Calhoun, CIH and Joe Nieusma, Ph.D. of Affygility Solutions discuss Category 4 and Category 5 Potent Compounds - Understanding the Risks.
Items covered include:
- Review of the last podcast
- What factors go into determining an active pharmaceutical ingredients as a Category 4 or Category 5 potent compound
- We provide examples of Category 4 and Category 5 potent compounds
- Review upcoming events and happenings related to environmental, health and safety in the biotechnology, pharmaceutical, and medical device industry.
If you have any questions please contact Affygility Solutions at 303-884-3028 or visit the Affygility Solutions website.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
